Screener
Protagonist Therapeutics PTGX Business Segments — Investment Income Interest
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Employee wages and benefits - discovery (2) | (2,668) | (2,188) | (5,816) | (4,515) |
| Employee wages and benefits - development (2) | (4,949) | (4,658) | (10,901) | (10,142) |
| Employee wages and benefits - general and administrative | (4,357) | (3,483) | (9,080) | (7,315) |
| Stock-based compensation expense | (14,037) | (10,912) | (28,556) | (24,714) |
| Other segment items (3) | (81) | 36 | (28) | 118 |
| Interest income | 6,429 | 7,406 | 12,305 | 14,979 |
| Income tax expense | (2,265) | (172) | (763) | (172) |
| Consolidated net income (loss) | $162,849 | $(34,771) | $166,632 | $(46,426) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Protagonist Therapeutics's business segments — investment income interest?
- Protagonist Therapeutics (PTGX) reported business segments — investment income interest of $6.43M in Q2 2026.
- How has Protagonist Therapeutics's business segments — investment income interest changed year-over-year?
- Protagonist Therapeutics's business segments — investment income interest decreased by 13.2% year-over-year, from $7.41M to $6.43M.
- What is the long-term trend for Protagonist Therapeutics's business segments — investment income interest?
- Over 3 years (2022 to 2025), Protagonist Therapeutics's business segments — investment income interest has grown at a 92.1% compound annual growth rate (CAGR), from $4.06M to $28.79M.
- What does business segments — investment income interest mean?
- This represents the interest income generated from the company's cash, cash equivalents, and marketable securities. For clinical-stage companies, this is a vital source of non-dilutive capital that helps offset operating expenses. It reflects the company's treasury management strategy and the yield on its liquid assets.
Ask your AI about Protagonist Therapeutics's business segments — investment income interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude